Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Tech Today.
Press releases published on May 6, 2025

AppSignal Closes $22 Million Growth Investment to Expand Reach in the Application Performance Monitoring Market
AMSTERDAM and AUSTIN, Texas, May 06, 2025 (GLOBE NEWSWIRE) -- AppSignal today announced the close of a $22 million Series A funding round led by Elsewhere Partners to accelerate its global expansion, meeting the increasing need for comprehensive, yet …

Shoals Technologies Group, Inc. Reports Financial Results for First Quarter 2025
– Quarterly Revenue of $80.4 million – – Gross Margin of 35.0% – – Net Loss of $(0.3) million – – Adjusted EBITDA1 of $12.8 million – – Backlog and Awarded Orders Increased 5% Year-Over-Year to $645.1 million – – Provides Second Quarter and Full …

Transpire Bio Announces R&D and Manufacturing Expansion
SUNRISE, Fla., May 06, 2025 (GLOBE NEWSWIRE) -- Transpire Bio, an integrated clinical-stage biopharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, today announced that it has signed an agreement to expand …

Upstream Bio Reports First Quarter 2025 Financial Results and Accelerates Guidance on All Clinical Programs
– Top-line data from Phase 2 clinical trial of verekitug in patients with chronic rhinosinusitis with nasal polyps expected in the third quarter of 2025 – – Top-line data from Phase 2 clinical trial of verekitug in patients with severe asthma now expected …

CYCLACEL PHARMACEUTICALS, INC. ANNOUNCES EXECUTION OF SHARE EXCHANGE AGREEMENT TO MAKE FITTERS SDN. BHD. ITS WHOLLY-OWNED SUBSIDIARY TO ACCELERATE GROWTH AND STOCKHOLDER VALUE
KUALA LUMPUR, MALAYSIA, May 06, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”) today announced that it entered into an Exchange Agreement with FITTERS Diversified Berhad (9318.KL; “FITTERS …

GSI Technology to Participate in the Sidoti May Micro-Cap Virtual Conference
SUNNYVALE, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- GSI Technology, Inc. (Nasdaq: GSIT), the inventor of the Associative Processing Unit (APU), a paradigm shift in artificial intelligence (AI) and high-performance compute (HPC) processing providing true …

CLEAR Announces $0.125 Regular Quarterly Cash Dividend
NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- Clear Secure, Inc. (NYSE: YOU) ("CLEAR" or the "Company") today announced that its Board of Directors (the "Board") declared a regular quarterly dividend of $0.125 per share, payable on June 17, 2025 to holders of …

First Atlantic Nickel Receives Junior Exploration Assistance Grant from Province of Newfoundland and Labrador
VANCOUVER, British Columbia, May 06, 2025 (GLOBE NEWSWIRE) -- First Atlantic Nickel Corp. (TSXV: FAN) (OTCQB: FANCF) (FSE: P21) ("First Atlantic" or the "Company") expresses its gratitude to the Province of Newfoundland …

Italfarmaco Announces U.S. FDA Grants Fast Track Designation to Givinostat in Treatment of Polycythemia Vera
MILAN, Italy, May 6, 2025 – Italfarmaco S.p.A. announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to givinostat for the treatment of patients with polycythemia vera (PV), a rare haematologic cancer, for …

Integral Metals Reports Monazite-Dominant REE Mineralization at Woods Creek
CALGARY, Alberta, May 06, 2025 (GLOBE NEWSWIRE) -- Integral Metals Corp. (CSE: INTG | OTC: ITGLF | FSE: ZK9) (the “Company” or “Integral”) is pleased to report detailed mineralogical analysis by Quantitative Evaluation of Materials by Scanning (QEMSCAN) …

Angelini Ventures Co-Leads $45 Million Series B Financing of Nuevocor to Advance Transformative Treatment for Genetic Dilated Cardiomyopathy
Angelini Ventures marks its first investment in the cardiovascular and gene therapy space – and first in Asia, further diversifying its strong and growing portfolio Rome, Italy - 6 May 2025 – Angelini Ventures, the corporate venture firm of Angelini …

Novaremed Announces Completion of Enrollment in NIH-sponsored Phase 2b Study with Non-opioid NRD.E1 for the Treatment of Chronic Pain Associated with Diabetic Peripheral Neuropathy
Last patient first visit (LPFV) marks completion of enrollment of 127 adult and elderly patients in the randomized, placebo-controlled trial -- topline data is expected in Q4 2025 This study builds on Phase 2a proof-of-concept results, which showed a …

Discovery Files Final Base Shelf Prospectus
TORONTO, May 05, 2025 (GLOBE NEWSWIRE) -- Discovery Silver Corp. (TSX: DSV, OTCQX: DSVSF) (“Discovery” or the “Company”) is pleased to announce that it has filed a final short form base shelf prospectus (the “Shelf Prospectus”) with the securities …

Aura Declares Dividend of US$0.40 per share and US$0.1333 per BDR based on Q1 2025 Results, resulting in a Dividend Yield of 11%¹ in the LTM
ROAD TOWN, British Virgin Islands, May 05, 2025 (GLOBE NEWSWIRE) -- Aura Minerals Inc. (TSX: ORA, B3: AURA33 and OTCQX: ORAAF) (“Aura” or the “Company”) announced today that the Company’s Board of Directors (the “Board”) has declared and approved the …